Results 241 to 250 of about 1,241,995 (300)

End-of-life healthcare utilization and costs according to cause of death: a retrospective study. [PDF]

BMC Geriatr
Bosson-Rieutort D, Boulianne JF, Duc J, Barbat-Artigas S, Strumpf EC.   +4 more
europepmc   +1 more source

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte, Lucy Norcliffe‐Kaufmann, Maria Luisa Cotrina, Zenith Khan, Kaia Dalamo, Patricio Millar Vernetti, Matthew Lawless, Elisabetta Morini, Monica Salani, Marla Weetall, Jana Narasimhan, Agostino G. Rocha, Susan A. Slaugenhaupt, Horacio Kaufmann   +13 more
wiley   +1 more source

Functional Outcomes of Anatomic Total Shoulder Arthroplasty in Patients Over 60 Years Old: A Retrospective Study (2019-2024). [PDF]

Cureus
Abbakr L, Nadimi J, Dragonas C, Fontalis A, Tariq M, Leivadiotou D.   +5 more
europepmc   +1 more source

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund, Johan Reutfors, Thomas Frisell, Fredrik Piehl   +3 more
wiley   +1 more source

Low serum albumin levels and the nongerminal center B-cell subtype according to the Hans algorithm as strong prognostic factors in ≥ 80-year-old patients with large B-cell lymphoma treated with rituximab-containing chemotherapy. [PDF]

Ann Hematol
Kawashima I, Nakadate A, Hyuga H, Matsuura M, Sakamoto Y, Suzuki J, Kumagai T, Suzuki M, Yamanda-Koshiishi M, Yamamoto T, Nakajima K, Oishi N, Kondo T, Kirito K.   +13 more
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Impact of age on short-term outcomes and oncologic prognosis after radical surgery for colorectal cancer over 60. [PDF]

Int J Colorectal Dis
Chen JJ, Li ZL, Yang Y, Wang ZJ.
europepmc   +1 more source

Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang, Lu Lu, Hui Gao, Qi Zhang, Jing Xiao, Josemir W. Sander, Weixi Xiong, Dong Zhou   +7 more
wiley   +1 more source

Epidemiological profile and temporal trend of hospitalizations for Alzheimer's disease in the Brazilian Unified Health System (2012-2022). [PDF]

Arq Neuropsiquiatr
Bertella E, Correa FAA, Iop RDR, Nazario NO, Silva FCD, Belmonte LM.   +5 more
europepmc   +1 more source

Respiratory function and its predictive value for adverse health outcomes in adults aged 80 and over

, 2017
Eralda Hegendörfer
openalex   +1 more source